Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
QuantumLeap Healthcare Collaborative
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
NKGen Biotech, Inc.
VA Office of Research and Development
Alliance for Clinical Trials in Oncology